Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Long-Term Deferred Tax: 2016-2021

  • cbdMD's Long-Term Deferred Tax rose 30.50% to $13.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $13.0 million, marking a year-over-year increase of 30.50%. This contributed to the annual value of $13.0 million for FY2021, which is 30.50% up from last year.
  • As of Q3 2021, cbdMD's Long-Term Deferred Tax stood at $13.0 million, which was up 30.50% from $10.0 million recorded in Q3 2020.
  • Over the past 5 years, cbdMD's Long-Term Deferred Tax peaked at $13.0 million during Q3 2021, and registered a low of $19,000 during Q1 2018.
  • Its 3-year average for Long-Term Deferred Tax is $9.9 million, with a median of $10.0 million in 2020.
  • As far as peak fluctuations go, cbdMD's Long-Term Deferred Tax plummeted by 33.88% in 2018, and later spiked by 322.65% in 2019.
  • Quarterly analysis of 5 years shows cbdMD's Long-Term Deferred Tax stood at $2.4 million in 2017, then slumped by 33.88% to $1.6 million in 2018, then skyrocketed by 322.65% to $6.8 million in 2019, then skyrocketed by 46.91% to $10.0 million in 2020, then soared by 30.50% to $13.0 million in 2021.
  • Its Long-Term Deferred Tax stands at $13.0 million for Q3 2021, versus $10.0 million for Q3 2020 and $6.8 million for Q3 2019.